This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Turner's syndrome
Q17_TURNE_SYNDR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
90 |
4. Check minimum number of eventsNone |
90 |
5. Include endpointsNone |
90 |
6. Filter based on genotype QC (FinnGen only) |
90 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q9
- Name in latin
- Syndroma Turner
Similar endpoints
↥List of similar endpoints to
Turner's syndrome
based on the number of shared cases.
Similar with more cases:
- Chromosomal abnormalities, not elsewhere classified
- Exclusions for E4_PCOS_BROAD
- Congenital malformations, deformations and chromosomal abnormalities
- Exclusions for E4_PCOS_CONSORTIUM
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1030 | 965 | 61 |
| Only index persons | 909 | 853 | 56 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.00 |
| Only index persons | 0.03 | 0.03 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 15.85 | 16.16 | 9.17 |
| Only index persons | 17.47 | 18.00 | 9.51 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 90 | 84 | 6 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.00 |
| Median age at first event (years) | 20.70 | 21.52 | 9.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
38
7.34
12.98
2.7
1.7
u/l
6.6
11.9
0.77
16
30
(40765089) Chromosome analysis panel - Blood by G-banded
12
7
19.50
8.33
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
270
3.05
6.32
2.0
1.4
u/ml
0.6
2.0
1.27
14
64
(3007164) IgA [Mass/volume] in Serum or Plasma
46
243
2.83
5.53
2.0
1.3
g/l
2.0
2.0
0.07
20
134
(36660697) Celiac disease serology panel - Serum
27
111
3.05
5.07
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
49
297
2.43
4.11
3.4
2.3
nmol/l
66.2
72.1
1.04
49
273
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
5
10.48
3.01
7.0
4.2
ug/l
2.9
2.2
—
5
5
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
160
2.20
2.84
1.5
1.5
mmol/l
1.4
1.3
0.20
24
144
(3008898) HLA-B27 [Presence]
0
68
0.00
2.74
0.0
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
8
21
4.07
2.53
8.8
19.9
%
94.4
96.1
—
8
21
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
22
3.89
2.43
8.8
19.1
%
1.2
1.1
—
8
22
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
22
3.89
2.43
8.8
19.1
%
0.6
0.7
—
8
22
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
16
79
2.25
2.00
2.6
2.0
mmol/l
2.4
2.4
0.20
16
70
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
11
4.74
1.97
1.0
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
27
167
1.88
1.87
4.3
5.3
inr
0.9
1.1
—
8
60
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
13
4.00
1.74
1.2
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
93
2.02
1.65
1.7
2.5
u/l
1845.2
5212.0
—
6
32
(40761536) Microorganisms panel - Urine sediment
14
72
2.12
1.59
3.0
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
17
95
1.97
1.56
2.3
3.2
ng/l
1463.3
577.9
—
10
41
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
88
2.00
1.53
1.4
1.3
iu/ml
180.0
137.0
—
5
44
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
22
2.85
1.46
10.8
17.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
300
0.57
1.37
1.4
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
17
100
1.86
1.35
4.1
3.5
mg/mmol
7.9
20.3
0.60
12
65
(3019060) Gas panel - Arterial blood
5
19
2.72
1.23
2.2
4.6
—
—
—
0
0
(3044889) 12 lead EKG panel
48
382
1.55
1.22
3.0
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
18
113
1.74
1.17
3.2
3.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
20
2.58
1.16
1.2
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
20
2.58
1.16
1.6
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
73
646
1.69
1.11
3.4
3.0
mmol/l
5.6
5.5
0.31
68
599
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
66
734
0.62
1.09
4.0
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
24
166
1.61
1.09
1.6
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
54
1.96
1.01
1.3
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
36
2.02
0.99
1.1
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
27
2.31
0.95
6.3
2.9
%
138.0
167.9
—
6
27
(4035726)
8
43
1.94
0.90
1.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
90
1.66
0.84
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
131
0.57
0.81
2.6
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
26
0.00
0.80
0.0
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
67
1.73
0.79
6.3
9.4
mmol/l
23.9
24.8
0.33
11
67
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
55
1.71
0.76
1.3
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
25
2.06
0.74
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
58
1.61
0.72
1.7
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
11
69
1.68
0.72
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
25
317
0.71
0.71
2.1
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
43
361
1.37
0.71
6.7
8.1
e9/l
0.0
0.0
0.49
37
299
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
86
1.60
0.71
1.3
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
772
1.70
0.70
8.9
8.1
u/l
39.1
22.2
2.57
82
746
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
241
0.68
0.69
2.7
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
48
543
0.75
0.62
3.1
3.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
170
0.66
0.61
2.8
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
23
0.00
0.59
0.0
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
12
82
1.53
0.58
2.8
2.7
s
30.7
29.4
0.56
12
82
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
9
59
1.58
0.57
2.3
2.9
u/l
234.4
225.8
—
9
59
(3000991) Gas panel - Venous blood
9
59
1.58
0.57
9.8
12.1
—
—
—
0
0
(3019225) pH of Specimen
6
39
1.58
0.54
1.7
6.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
6
40
1.53
0.52
11.5
3.5
mmol/l
1.2
1.2
—
6
33
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
262
0.74
0.52
2.7
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
45
1.60
0.50
2.1
2.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
41
465
0.78
0.50
5.7
8.2
e9/l
3.9
3.8
0.11
34
406
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
174
0.70
0.49
1.5
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
20
157
1.35
0.49
4.0
2.8
mmol/l
7.4
8.1
0.21
15
139
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
85
0.56
0.48
1.2
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
85
0.56
0.48
1.2
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
85
0.56
0.48
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
85
0.56
0.48
1.2
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
34
290
1.28
0.47
8.6
7.1
mmol/l
1.2
1.2
0.32
29
253
(3022217) INR in Platelet poor plasma by Coagulation assay
5
32
1.59
0.43
42.6
10.3
—
1.0
—
0
8
(3000492) Spirometry study
8
59
1.39
0.42
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
34
1.50
0.41
2.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
11
80
1.43
0.40
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
79
756
1.37
0.37
12.9
11.3
%
38.0
39.5
1.00
67
654
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
187
0.76
0.36
2.1
3.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
42
1.46
0.36
1.0
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
25
212
1.25
0.35
1.8
1.5
pmol/l
106.2
94.2
0.57
12
97
(40758558) Short blood count panel - Blood
16
196
0.78
0.34
5.8
7.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
30
261
1.22
0.34
4.4
5.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
65
611
1.23
0.33
10.3
8.1
ml/min/173m2
101.6
98.1
0.69
56
478
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
95
0.71
0.33
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
106
0.73
0.31
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
108
0.72
0.31
1.4
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
12
150
0.77
0.30
1.9
2.3
e6/l
6.8
7.2
0.06
12
137
(3044640) Blood type and Crossmatch panel - Blood
26
227
1.20
0.28
1.9
2.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
71
0.69
0.27
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
71
0.69
0.27
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
71
0.69
0.27
1.2
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
71
0.69
0.27
4.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
72
0.68
0.27
1.0
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
73
0.67
0.27
1.2
1.5
—
—
—
0
0
(3036489) Thrombin time
5
37
1.37
0.24
3.0
2.4
s
24.6
20.9
—
5
31
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
90
0.76
0.24
2.1
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
22
192
1.19
0.23
1.9
3.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
5
41
1.23
0.22
1.2
1.9
mg/l
1.3
2.6
—
5
25
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
330
0.86
0.22
2.2
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
97.1
—
0
10
(3045424) Erythrocytes [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
110
0.80
0.21
1.4
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
120.5
—
0
12
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
12
0.00
0.21
0.0
1.8
—
13.3
—
0
12
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
253.5
—
0
13
(4306422)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(4094501)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18
157
1.18
0.19
1.8
2.7
ng/l
20.1
18.1
0.10
11
61
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
67
1.21
0.17
1.9
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
27
295
0.88
0.17
2.9
3.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
28
256
1.14
0.17
2.7
2.1
—
—
—
0
0
(3012544) pH of Venous blood
8
72
1.12
0.16
3.3
6.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
76
0.77
0.16
1.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
75
0.79
0.16
1.2
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
75
0.79
0.16
1.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
75
0.79
0.16
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
243
0.87
0.16
1.6
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
77
1.19
0.16
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
269
1.12
0.13
1.7
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
30
279
1.11
0.13
1.9
1.9
—
—
—
0
0
(3013512) EKG study
14
123
1.16
0.13
3.1
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
21
191
1.13
0.13
2.0
2.8
e6/l
0.1
0.2
1.17
12
150
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
25
231
1.11
0.12
2.0
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
37
388
0.92
0.10
2.6
3.2
estimate
0.0
0.0
—
9
80
(3018095) Leukocytes [#/volume] in Urine
25
267
0.91
0.10
2.6
3.4
e6/l
77.2
64.5
0.09
16
179
(3022313) Gas panel - Capillary blood
5
46
1.09
0.10
3.8
11.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
12
134
0.88
0.09
1.9
2.4
mosm/kgh2o
478.1
549.4
0.70
12
119
(3009261) Glucose [Presence] in Urine by Test strip
37
387
0.93
0.09
2.7
3.3
estimate
0.0
0.0
—
10
80
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
156
1.11
0.09
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
28
296
0.92
0.09
1.8
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
61
0.81
0.08
6.2
9.5
kpa
5.6
5.0
—
5
56
(3011288) Drugs identified in Urine by Screen method
5
60
0.82
0.08
1.8
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
1.3
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
71
0.83
0.08
1.2
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
73
1.11
0.08
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
224
0.92
0.07
3.1
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
234
0.92
0.07
1.7
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
37
385
0.93
0.07
3.6
4.6
estimate
0.0
0.0
—
10
81
(36304419) Bacteria [Presence] in Urine
21
197
1.09
0.07
2.1
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
23
217
1.08
0.07
1.6
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
38
366
1.07
0.06
2.9
4.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
40
413
0.94
0.06
4.3
5.8
e9/l
0.1
0.2
1.91
34
369
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
14
150
0.92
0.04
1.4
2.3
u/l
380.0
634.3
0.24
14
145
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
160
0.93
0.04
1.7
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
91
1.11
0.04
1.1
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
39
400
0.96
0.03
3.9
5.7
e9/l
0.0
0.0
0.24
33
358
(3001604) Monocytes [#/volume] in Blood
39
398
0.96
0.02
3.9
5.7
e9/l
0.5
0.5
0.10
33
356
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
77
768
1.02
0.00
9.5
10.3
mg/l
25.4
19.7
0.72
61
551
(3002582) Erythrocytes [#/volume] in Urine
22
217
1.02
0.00
2.0
2.7
e6/l
12.1
53.3
1.44
15
173
(3031040) Bacteria [#/volume] in Urine by Automated count
52
515
1.02
0.00
2.5
3.9
—
50.0
—
0
7
(3037522) Nuclear Ab [Titer] in Serum
13
125
1.05
0.00
1.5
1.5
—
680.0
—
0
23
(3029937) Albumin [Presence] in Urine by Test strip
21
209
1.01
0.00
2.9
3.2
estimate
0.0
0.0
—
9
81
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
59
0.84
0.00
4.4
4.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
5.4
—
26.4
—
0
8
(3004616) Nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
5
59
0.84
0.00
6.2
9.7
mmol/l
3.4
1.0
—
5
43
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.8
—
0.6
—
0
6
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
6.0
—
0
6
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
0.3
—
0
8
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.3
—
6.4
—
0
6
(3020491) Glucose [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
5.5
—
0
6
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.3
—
1.0
—
0
6
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
65
0.92
0.00
1.2
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
6
68
0.87
0.00
1.3
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
107.6
—
0
7
(3026250) Tacrolimus [Mass/volume] in Blood
0
7
0.00
0.00
0.0
68.9
—
6.3
—
0
7
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.0
—
38.5
—
0
5
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
80.8
—
0
5
(40768797) Stomach Pathology biopsy report
7
76
0.91
0.00
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_TURNE_SYNDR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_TURNE_SYNDR | 4.191 [3.01, 5.84] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.156 |
During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 862 females with Q17_TURNE_SYNDR died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have Q17_TURNE_SYNDR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.364% | No data |
| 5 | 2.293% | No data |
| 10 | 5.834% | No data |
| 15 | 10.872% | No data |
| 20 | 18.565% | No data |
Relationships between endpoints
↥Index endpoint: Q17_TURNE_SYNDR – Turner's syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data